We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Comparing Single-Cell Intracellular Proteome with Traditional Phosphoflow

Learn how IsoPlexis’ Intracellular Signaling Omics reveals phosphoproteomic signaling networks in days, not weeks, with fully optimized and validated panels.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

How to overcome the limitations of traditional phosphoflow
How to eliminate the need for complex panel design steps of traditional phosphoflow
How to reveal multiple pathways to drug resistance
How single-cell proteomics predicts the success of combination therapy
A Deeper Look

More about this

Overcome the Limits of Traditional Phosphoflow

Traditional phosphoflow methods have overly complicated workflows and do not provide complete insights into the entire signaling network.

IsoPlexis’ Single-Cell Intracellular Proteome targets 500-1500 individual cells per chip with 15+ analytes per single cell, uniquely measuring cellular communication via phosphorylation events, providing complete insights into the entire signaling network and revealing critical adaptive resistance pathways.

Download this Tech Note to learn more!

Get the